Atlas Trials

UI-Romi-02; Romiplostim Added to Standard of Care for Treatment Naive and Relapsed or Refractory Severe Aplastic Anemia

Clinical trial NCT07001254 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07001254
Sponsor
Anjali Sharathkumar
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Aplastic Anemia
Start date
2026-08-01
Primary completion
2031-12-31
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.